Thanks dcheckers for that.
You state "It is apparently important for the whole process to be monitored under the trial. So any patient already diagnosed AND treated (surgery and/or chemo) prior to being introduced to Prima cannot be enrolled in Canvas."
Are you suggesting patients in the CANVAS study are being treated PRIOR to chemotherapy?
This is contradictory to what the Company (MR) has told me?
sydney shareholder presentation, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 28.0¢ | $1.286M | 4.321M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 235190 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 19778 | 3 |
View Market Depth
| Last trade - 12.30pm 02/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |